Details of the Drug Formulaction

General Information of Drug Formulation (ID: F14248)

Formulation Name
Mirtazapine 30 mg tablet
Company
Watson Laboratories
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Mirtazapine DML53ZJ Depression 6A70-6A7Z Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Acetaldehyde E00003 177 Flavoring agent
Alpha-tocopherol E00243 14985 Antimicrobial preservative; Antioxidant
Aspartame E00402 134601 Flavoring agent
Caryophyllene E00471 5281515 Flavoring agent
Crospovidone E00626 Not Available Disintegrant
Dextrin E00359 62698 Binding agent; Diluent; Microencapsulating agent; Stiffening agent; Suspending agent; Viscosity-controlling agent
Dimethyl benzyl carbinyl acetate E00196 9024 Adsorbent; Flavoring agent
Ethyl butyrate E00153 7762 Flavoring agent
Magnesium stearate E00208 11177 lubricant
Mannitol E00103 6251 Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Silicon dioxide E00670 Not Available Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium stearyl fumarate E00545 23665634 lubricant
Xylitol E00136 6912 Coating agent; Diluent; Emollient; Flavoring agent; Humectant